These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28669329)

  • 1. Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.
    Mitsiou E; Boutari C; Kotsis V; Georgianou E; Doumas M; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2018; 16(4):393-400. PubMed ID: 28669329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment.
    Katsiki N; Imprialos K; Vlachopoulos C
    Curr Vasc Pharmacol; 2018; 16(4):401-404. PubMed ID: 29210656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
    Kargiotis K; Athyros VG; Giouleme O; Katsiki N; Katsiki E; Anagnostis P; Boutari C; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jul; 21(25):7860-8. PubMed ID: 26167086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial Destiffening in Previously Untreated Mild Hypertensives After 1 Year of Routine Clinical Management.
    Rodilla E; Millasseau S; Costa JA; Pascual JM
    Am J Hypertens; 2017 May; 30(5):510-517. PubMed ID: 27993838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil.
    Harada PH; Bensenõr IJM; Drager LF; Goulart AC; Mill JG; Lotufo PA
    Atherosclerosis; 2019 May; 284():59-65. PubMed ID: 30875494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study.
    Tuttolomondo A; Petta S; Casuccio A; Maida C; Corte VD; Daidone M; Di Raimondo D; Pecoraro R; Fonte R; Cirrincione A; Zafonte R; Cabibi D; Cammà C; Di Marco V; Licata A; Magliozzo F; Marchesini G; Merlino G; Craxì A; Pinto A
    Cardiovasc Diabetol; 2018 Feb; 17(1):28. PubMed ID: 29452601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Arterial Hypertension Control Enough to Improve Aortic Stiffness in Untreated Patients With Hypertension? A 3-Year Follow-Up Study.
    Triantafyllidi H; Trivilou P; Ikonomidis I; Kontsas K; Tzortzis S; Pavlidis G; Lekakis J
    Angiology; 2015 Sep; 66(8):759-65. PubMed ID: 25274527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.
    Ikdahl E; Rollefstad S; Hisdal J; Olsen IC; Pedersen TR; Kvien TK; Semb AG
    PLoS One; 2016; 11(4):e0153440. PubMed ID: 27093159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.
    Sunbul M; Agirbasli M; Durmus E; Kivrak T; Akin H; Aydin Y; Ergelen R; Yilmaz Y
    Atherosclerosis; 2014 Dec; 237(2):490-3. PubMed ID: 25463079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension.
    Catena C; Bernardi S; Sabato N; Grillo A; Ermani M; Sechi LA; Fabris B; Carretta R; Fallo F
    Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):389-93. PubMed ID: 22796347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma VEGF and IL-8 Levels in Patients with Mixed Dyslipidaemia. Effect of Rosuvastatin Monotherapy or its Combination at a Lower Dose with Omega-3 Fatty Acids: A Pilot Study.
    Chantzichristos VG; Agouridis AP; Moutzouri E; Stellos K; Elisaf MS; Tselepis AD
    Curr Vasc Pharmacol; 2016; 14(5):474-480. PubMed ID: 27041244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness.
    Li N; Zhang GW; Zhang JR; Jin D; Li Y; Liu T; Wang RT
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):218-23. PubMed ID: 25456154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.
    Cosenso-Martin LN; Giollo-Júnior LT; Fernandes LAB; Cesarino CB; Nakazone MA; Machado MN; Yugar-Toledo JC; Vilela-Martin JF
    Acta Diabetol; 2018 Dec; 55(12):1237-1245. PubMed ID: 30094725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
    Sfikas G; Psallas M; Koumaras C; Imprialos K; Perdikakis E; Doumas M; Giouleme O; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2021; 19(5):572-581. PubMed ID: 33059580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of rosuvastatin on arterial stiffness in hyperlipidemia patients].
    Wang P; Liu Y; Wang Z; Wang Z; Zhao N; Ye H; Ren L
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2452-4. PubMed ID: 25400055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention of long-acting nifedipine GITS reduces brachial-ankle pulse wave velocity and improves arterial stiffness in Chinese patients with mild hypertension: a 24-week, single-arm, open-label, prospective study.
    Zhang J; Wang Y; Hu H; Yang X; Tian Z; Liu D; Gu G; Zheng H; Xie R; Cui W
    Drug Des Devel Ther; 2016; 10():3399-3406. PubMed ID: 27799740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension.
    Raptis AE; Markakis KP; Mazioti MC; Ikonomidis I; Maratou EP; Vlahakos DV; Kotsifaki EE; Voumvourakis AN; Tsirogianni AG; Lambadiari VA; Lekakis JP; Raptis SA; Dimitriadis GD
    Am J Hypertens; 2015 Jan; 28(1):22-9. PubMed ID: 24994608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of low-dose aspirin on aortic stiffness in hypertensive patients.
    Pietri P; Vlachopoulos C; Terentes-Printzios D; Xaplanteris P; Aznaouridis K; Petrocheilou K; Stefanadis C
    Vasc Med; 2014 Dec; 19(6):452-7. PubMed ID: 25362110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients.
    Betto M; Fares J; Saliba N; Ballout H
    Ann Saudi Med; 2017; 37(5):366-374. PubMed ID: 28988251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.